XML 69 R49.htm IDEA: XBRL DOCUMENT v3.24.0.1
Long-Term Investments (Details) - Schedule of Statement of Operation - USD ($)
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
BioFirst [Member]    
Condensed Income Statements, Captions [Line Items]    
Net sales $ 739 $ 23,079
Gross profit 291 5,747
Net loss (986,181) (993,643)
Share of losses from investments accounted for using the equity method
Rgene [Member]    
Condensed Income Statements, Captions [Line Items]    
Net sales
Gross profit
Net loss (231,445) (450,995)
Share of losses from investments accounted for using the equity method